Menstrual phase, depressive symptoms, and allopregnanolone during short-term smoking cessation

Experimental and Clinical Psychopharmacology

Volumn 21, Issue 6, 2013, Pages 427-433

  Allen, Alicia M ^a   al'Absi, Mustafa ^a   Lando, Harry ^a   Hatsukami, Dorothy ^a   Allen, Sharon S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Abstinence; Depression; Females; Hormones; Nicotine

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE;

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; FEMALE; FOLLICULAR PHASE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENTAL PATIENT; PREMENOPAUSE; RELAPSE; RISK FACTOR; SCREENING TEST; SMOKING; SMOKING CESSATION; YOUNG ADULT;

ADOLESCENT; ADULT; COMORBIDITY; CROSS-OVER STUDIES; DEPRESSION; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; PREGNANOLONE; RECURRENCE; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84890960815     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0034075     Document Type: Article

References (41)

1. Allen, S. S., Bade, T., Center, B., Finstad, D., & Hatsukami, D. (2008). Menstrual phase effects on smoking relapse. Addiction, 103, 809-821. doi:10.1111/j.1360-0443.2008.02146
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Andreen, L., Sundstrom-Poromaa, I., Bixo, M., Nyberg, S., & Backstrom, T. (2006). Allopregnanolone concentration and mood: A biomodal association in postmenopausal women treated with oral progesterone. Psychopharmacology, 187, 209 -221. doi:10.1007/s00213- 006 - 0417-0
4. Anker, J. J., & Carroll, M. E. (2010). Sex differences in the effects of allopregnanolone on yohimbine-induced reinstatement of cocaine seeking in rats. Drug and Alcohol Dependence, 107, 264-267. doi:10.1016/ j.drugalcdep.2009.11.002
5. Anker, J. J., & Carroll, M. E. (2011). Females are more vulnerable to drug abuse than males: Evidence from preclinical studies and the role of ovarian hormones. Current Topics in Behavioral Neuroscience, 8, 73-96.
6. Anker, J. J., Perry, J. L., Gliddon, L. A., & Carroll, M. E. (2008). Impulsivity predicts the escalation of cocaine self-administration in rats. Pharmacology, Biochemistry and Behavior, 93, 343-348. doi:10.1016/ j.pbb.2009.05.013
7. Benowitz, N. L., Bernert, J. T., Caraballo, R. S., Holiday, D. B., & Wang, J. (2008). Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. American Journal of Epidemiology, 169, 236-248. doi:10.1093/aje/kwn301
8. Birzniece, V., Backstrom, T., Johansson, I. M., Lindblad, C., Lundgren, P., Lofgren, M., . . . Zhu, D. (2006). Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems. Brain Research Reviews, 51, 212-239. doi:10.1016/j.brainresrev.2005.11.001
9. Borrelli, B., Bock, B., King, T., Pinto, B., & Marcus, B. H. (1996). The impact of depression on smoking cessation in women. American Journal of Preventive Medicine, 12, 378-387. doi:10.1093/aje/kwn301
10. Bowen, C. A., Purdy, R. H., & Grant, K. A. (1999). Ethanol-like discriminative stimulus of endogenous neuroactive steroids: Effect of ethanol training dose and dosing procedure. Journal of Pharmacology and Experimental Therapeutics, 289, 405-411. doi:10.1016/j.pbb.2008.08 .005
11. Carpenter, M. J., Saladin, M. E., Leinbach, A. S., LaRowe, S. D., & Upadhyaya, H. P. (2008). Menstrual phase effects on smoking cessation: A pilot feasibility study. Journal of Women's Health, 17, 293-301. doi:10.1089/jwh.2007.0415
12. Carroll, M. E., & Anker, J. J. (2010). Sex differences and ovarian hormones in animal models of drug dependence. Hormones & Behavior, 58, 44-56.
13. Childs, E., Dlugos, A., & DeWit, H. (2010). Cardiovascular, hormonal and emotional responses to the TSST in relation to sex and menstrual cycle phase. Psychophysiology, 47, 550-559. doi:10.1111/j.1469-8986.2009 .00961.x
14. Franklin, T. R., & Allen, S. S. (2009). Influence of menstrual cycle phase on smoking cessation treatment outcome: A hypothesis regarding the discordant findings in the literature. Addiction, 1941-1942.
15. Franklin, T. R., Ehrman, R., Lynch, K. G., Harper, D., Sciortion, N., O'Brien, C. P., & Childress, A. R. (2008). Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: A retrospective analysis. Journal of Women's Health, 17, 287-292. doi:10.1089/jwh .2007.0423
16. Genazzani, A. R., Petraglia, F., Benardi, F., Casarosa, E., Salvestroni, C., Tonetti, A., . . . Luisi, M. (1998). Circulating levels of allopregnanolone in humans: Gender, age and endocrine influences. Journal of Clinical Endocrinology and Metabolism, 83, 2099-2103. doi:10.1210/jc.83.6 .2099
17. Girdler, S. S., & Klatzkin, R. (2007). Neurosteroids in the context of stress: Implications for depressive disorders. Pharmacology & Therapeutics, 116, 125-139. doi:10.1016/j.pharmthera.2007.05.006
18. Grant, K. A., Azarov, A., Shively, C. A., & Purdy, R. H. (1997). Discriminative stimulus effects of ethanol and 3 alpha-hydroxy-5 alcphapregnan- 20-one in relation to menstrual cycle phase in cynomolgus monkeys. Psychopharmacology, 130, 59 - 68. doi:10.1007/ s002130050211
19. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1445. doi:10.2105/ AJPH.77.11.1435
20. Klatzkin, R. R., Morrow, L. A., Light, K. C., Pedersen, C. A., & Girdler, S. S. (2006a). Histories of depression, allopregnanolone response to stress, and premenstrual symptoms in women. Biology Psychology, 71, 2-11. doi:10.1016/j.biopsycho.2005.02.007
21. Klatzkin, R. R., Morrow, L. A., Light, K. C., Pedersen, C. A., & Girdler, S. S. (2006b). Associations of histories of depression and PMDD with allopregnanolone concentrations following the oral administration of micronized progesterone. Psychoeuroendocrinology, 31, 1208-1219.
22. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-613. doi:10.1046/j.1525-1497.2001.016009606.x
23. Lynch, W. J., & Sofuoglu, M. (2010). Role of progesterone in nicotine addiction: Evidence form initiation to relapse. Experimental and Clinical Psychopharmacology, 18, 451-461. doi:10.1037/a0021265
24. Marx, C. E., Trost, W. T., Shampine, L., Behm, F. M., Giordano, L. A., Massing, M. E., & Rose, J. E. ( 2006). Neuroactive steroids, negative affect and nicotine dependence severity in male smokers. Psychopharmacology, 186, 462-472. doi:10.1007/s00213-005-0226-x
25. Mazure, C. M., Toll, B., McKee, S. A., Wu, R., & O'Malley, S. S. (2011). Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open-label trial of bupropion. Drug & Alcohol Dependence, 114, 68-72. doi:10.1016/j.drugalcdep.2010.07.024
26. Nakajima, M., & al'Absi, M. (2012). Predictors of smoking relapse in men and women: A prospective examination. Psychology of Addictive Behavior, 26, 633-637. doi:10.1037/a0027280
27. Nappi, R. E., Petraglia, F., Luisi, S., Polatti, F., Farina, C., & Genazzani, A. R. (2001). Serum allopregnanolone in women with postpartum "blues". Obstetrics & Gynecology, 97, 77-80. doi:10.1016/S0029- 7844(00)01112-1
28. Nyberg, S., Backstrom, T., Zingmark, E., Purdy, R., & Poromaa, I. S. (2007). Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Gynecological Endocrinology, 23, 257-266. doi:10.1080/09513590701253511
29. Perkins, K. A. (2001). Smoking cessation in women: Special considerations. CNS Drug, 15, 391-411. doi:10.2165/00023210-200115050- 00005
30. Perkins, K. A., & Scott, J. (2008). Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine & Tobacco Research, 10, 1245-1251. doi:10.1080/14622200802097506
31. Porcu, P., Sogliano, C., Cinus, M., Purdy, R. H., Biggio, G., & Concas, A. (2003). Nicotine-induced changes in cerebrocortical neuroactive steroids and plasma corticosterone concentrations in the rat. Pharmacology Biochemistry & Behavior, 74, 683- 690. doi:10.1016/S0091- 3057(02)01065-1
32. Purdy, R. H., Moore, P. H., Rao, P. N., Hagino, N., Yamaguchi, T., Schmidt, P., . . . Paul, S. M. (1990). Radioimmunoassay of 3-alphahydroxy- 5-alpha-pregnan-20-one in rat and human plasma. Steroids, 55, 290-296. doi:10.1016/0039-128X(90)90031-6
33. Roselli, C. E., Fin, T. J., Ronnekleiv-Kelly, S. M., Tanchuck, M. A., Kaufman, K. R., & Finn, D. A. (2011). Localization of brain 5-alphareductase messenger RNA in mice selectively bred for high chronic alcohol withdrawal severity. Alcohol, 45, 763-772. doi:10.1016/j .alcohol.2011.08.002
34. Sinnott, R. S., Mark, G. P., & Finn, D. A. (2002). Reinforcing effects of the neurosteroid allopregnanolone in rats. Pharmacology, Biochemistry and Behavior, 72, 923-929. doi:10.1016/S0091-3057(02)00776-1
35. Spitzer, R. L., Kroneke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of the PRIME-MD: The PHQ primary care study. Primary Care Evaluation of Mental Health Disorders, Patient Health Questionnaire. Journal of the American Medical Association, 282, 1737-1744. doi:10.1001/jama.282.18.1737
36. Strohle, A., Pasini, A., Romeo, E., Hermann, B., Spalletta, G., di Michele, F., . . . Rupprecht, R. (2000). Fluoxetine decreases concentrations of 3 alpha, 5 alpha tetrahydrodeoxycortisoterone (THDOC) in major depression. Journal of Psychiatric Research, 34, 183-186.
37. Torres, J. M., & Ortega, E. (2003). Alcohol intoxication increases allopregnanolone levels in female adolescent humans. Neuropsychopharmacology, 28, 1207-1209. doi:10.1038/sj.npp.1300170
38. U.S. Department of Health and Human Services (USDHHS). (2001). Women and Smoking: A report of the Surgeon General. Washington, DC: Public Health Service, Office of the Surgeon General. Retrieved from http://www.cdc.gov/tobacco/data_statistics/sgr/2001/complete_ report/index.htm
39. Wang, M., Seippel, L., Purdy, R. H., & Backstrom, T. (1996). Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, prenenolone sulfate, 5 alpha-pregnenlone-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20- one. Journal of Clinical Endocrinology and Metabolism, 81, 1076- 1082. doi:10.1210/jc.81.3.1076
40. Wittchen, H. U., Robins, L. N., Cottler, L. B., Sartorius, N., Burke, J. D., & Regier, D. (1991). Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The multicenter WHO/ADAMHA Field Trials. British Journal of Psychiatry, 159, 645-653. doi:10.1192/bjp.159.5.645
41. Zheng, P. (2009). Neurosteroid regulation of neurotransmitter release in the CNS: Action, mechanism and possible significance. Progress in Neurobiology, 89, 134-152.